In the highly regulated pharmaceutical industry, the quality and consistency of raw materials and intermediates are non-negotiable. For procurement managers and R&D scientists, a thorough understanding of product specifications is essential for ensuring the integrity of their research and manufacturing processes. This article delves into the critical parameters for pharmaceutical intermediates, using R-3-Amino-3-(2-thienyl)propionic acid (CAS 73495-10-0) as a key example.

R-3-Amino-3-(2-thienyl)propionic acid, a chiral amino acid derivative, is valued for its role as a building block in the synthesis of complex organic molecules, including Active Pharmaceutical Ingredients (APIs). When sourcing this compound, two primary specifications demand close attention: purity and physical form. As a reputable supplier, we emphasize providing intermediates with high purity levels, typically exceeding 97%, to minimize potential side reactions and ensure predictable outcomes in synthesis.

The physical form of an intermediate also impacts its handling, storage, and use in chemical processes. R-3-Amino-3-(2-thienyl)propionic acid is commonly supplied as a white to off-white solid or powder. This form is generally preferred for ease of weighing, dissolution, and integration into standard laboratory workflows. For procurement managers evaluating potential manufacturers, confirming the consistent availability of the desired physical form is as important as verifying purity.

When making purchasing decisions, it is advisable to request detailed Certificates of Analysis (CoAs) for each batch. These documents provide lot-specific data on purity, impurity profiles, and physical characteristics, ensuring that the purchased material meets project requirements. Building a relationship with a reliable manufacturer that prioritizes these specifications not only guarantees product quality but also contributes to a robust and efficient supply chain. For those seeking to buy R-3-Amino-3-(2-thienyl)propionic acid, prioritizing these critical specifications will lead to more successful R&D outcomes.